Hepatocellular carcinoma (HCC) is an aggressive malignant tumor, often associated with multidrug resistance, which limits the efficacy of conventional anticancer drugs [1]. In the last years, the possibility to affect tumour growth with multi-target therapies acting in synergy or on different targets has been highlighted. This approach enables to increase low-dose anticancer drug efficacy and limit systemic toxicity. In present study, the ability of the natural sesquiterpene ß-caryophyllene oxide (CRYO) to enhance the response of HCC to the first-line drug sorafenib (SOR) has been investigated. The cytotoxicity of CRYO alone or in combination with SOR was evaluated by MTT assay in different HCC cells [2,3]. Moreover, its ability to modulate both activity and expression of Pgp, MRP1/2 and STAT3 was measured2,3. At last, the sorafenib chemosensitization by the natural sesquiterpene was assessed in a liver xenograft model [2]. Despite a low cytotoxicity in our cellular models, CRYO was able to synergistically increase HCC cell sensitivity to SOR. CRYO also inhibited Pgp and MRP1/2 activity and reduced the SOR-induced expression of Pgp, MRP1/2 and STAT3 (Ser 727). In vivo experiments highlighted the combination of CRYO and SOR was able to inhibit the tumor growth of about 58%, despite a null effect of the anticancer drug alone. In conclusion, our results highlight the possible role of CRYO as a chemosensitizing agent in combination with SOR and support its potential usefulness to reverse the sorafenib-induced multidrug resistance by targeting Pgp and MRP1/2 transporters, and/or the STAT3 pathway. References [1] Fouquet et al., Oncotarget 2016, 7(22):32493. [2] Di Giacomo et al., Arch Toxicol;93(3):623-634. [3] Di Sotto et al., Int J Mol Sci. 2020;21(2):633

Chemosensitizing properties of ß-caryophyllene oxide in hepatocellular carcinoma / Di Giacomo, S; Briz, O; Monte, Mj; Sanchez-Vicente, L; Eufemi, M; Lozano, E; Di Sotto, A; Marin, Jjg.. - (2021), pp. 180-180. (Intervento presentato al convegno 69th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) tenutosi a Bonn (Germany), Virtual conference).

Chemosensitizing properties of ß-caryophyllene oxide in hepatocellular carcinoma

Di Giacomo S
Primo
;
Eufemi M;Di Sotto A;
2021

Abstract

Hepatocellular carcinoma (HCC) is an aggressive malignant tumor, often associated with multidrug resistance, which limits the efficacy of conventional anticancer drugs [1]. In the last years, the possibility to affect tumour growth with multi-target therapies acting in synergy or on different targets has been highlighted. This approach enables to increase low-dose anticancer drug efficacy and limit systemic toxicity. In present study, the ability of the natural sesquiterpene ß-caryophyllene oxide (CRYO) to enhance the response of HCC to the first-line drug sorafenib (SOR) has been investigated. The cytotoxicity of CRYO alone or in combination with SOR was evaluated by MTT assay in different HCC cells [2,3]. Moreover, its ability to modulate both activity and expression of Pgp, MRP1/2 and STAT3 was measured2,3. At last, the sorafenib chemosensitization by the natural sesquiterpene was assessed in a liver xenograft model [2]. Despite a low cytotoxicity in our cellular models, CRYO was able to synergistically increase HCC cell sensitivity to SOR. CRYO also inhibited Pgp and MRP1/2 activity and reduced the SOR-induced expression of Pgp, MRP1/2 and STAT3 (Ser 727). In vivo experiments highlighted the combination of CRYO and SOR was able to inhibit the tumor growth of about 58%, despite a null effect of the anticancer drug alone. In conclusion, our results highlight the possible role of CRYO as a chemosensitizing agent in combination with SOR and support its potential usefulness to reverse the sorafenib-induced multidrug resistance by targeting Pgp and MRP1/2 transporters, and/or the STAT3 pathway. References [1] Fouquet et al., Oncotarget 2016, 7(22):32493. [2] Di Giacomo et al., Arch Toxicol;93(3):623-634. [3] Di Sotto et al., Int J Mol Sci. 2020;21(2):633
2021
69th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA)
04 Pubblicazione in atti di convegno::04d Abstract in atti di convegno
Chemosensitizing properties of ß-caryophyllene oxide in hepatocellular carcinoma / Di Giacomo, S; Briz, O; Monte, Mj; Sanchez-Vicente, L; Eufemi, M; Lozano, E; Di Sotto, A; Marin, Jjg.. - (2021), pp. 180-180. (Intervento presentato al convegno 69th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) tenutosi a Bonn (Germany), Virtual conference).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1573682
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact